Catalyst + Talent. Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. With over 80 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance and provide superior, reliable manufacturing and packaging results.
Catalent develops. With our broad range of expert services we drive faster, more efficient development timelines to help you take more molecules to market and create more effective products.
Catalent delivers. As the world leader in drug delivery innovations, we have a proven record of enhancing bioavailability, solubility and permeability, improving ease and route of administration, and increasing patient compliance for better treatments.
Catalent supplies. Globally positioned to serve all your manufacturing and commercial packaging needs, we provide integrated solutions to take your product from design, to clinical trial, to plant, and to pharmacy.
Catalent. More products. Better treatments. Reliably supplied.™

Company Growth (employees)
Franklin Township, US
Size (employees)
10,800 (est)+18%
Catalent was founded in 2007 and is headquartered in Franklin Township, US

Catalent Office Locations

Catalent has offices in Franklin Township, Braeside, Jiaxing, Kakegawa and in 28 other locations
Franklin Township, US (HQ)
14 Schoolhouse Rd
Show all (32)

Catalent Financials and Metrics

Catalent Financials

Catalent's revenue was reported to be $1.8 b in FY, 2016

Revenue (Q1, 2018)

543.9 m

Gross profit (Q1, 2018)

140.1 m

Gross profit margin (Q1, 2018), %


Net income (Q1, 2018)

3.8 m

EBIT (Q1, 2018)

31.9 m

Market capitalization (13-Nov-2017)

4.8 b

Cash (30-Sep-2017)

601.4 m
Catalent's current market capitalization is $4.8 b.
USDFY, 2014FY, 2015FY, 2016


1.8 b1.8 b1.8 b

Revenue growth, %


Cost of goods sold

1.2 b1.2 b1.3 b

Gross profit

598.6 m615.3 m587.6 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018


418.3 m455.8 m446.6 m423 m454.9 m438 m442.2 m483.7 m532.6 m543.9 m

Cost of goods sold

293 m299.7 m294.4 m301.5 m302.8 m311.8 m318.1 m335.8 m365.2 m403.8 m

Gross profit

125.3 m156.1 m152.2 m121.5 m152.1 m126.2 m124.1 m147.9 m167.4 m140.1 m

Gross profit Margin, %

USDFY, 2014FY, 2015FY, 2016


74.4 m151.3 m131.6 m

Accounts Receivable

403.7 m372.4 m414.8 m


134.8 m132.9 m154.8 m

Current Assets

687.5 m737.5 m790.2 m
USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018


63.2 m84.1 m116.1 m151.4 m132.1 m255.8 m241.2 m601.4 m

Accounts Receivable

332.2 m336.4 m331.6 m308.2 m332 m343.7 m376.3 m366.3 m402.6 m410.5 m


142.4 m144.3 m142.2 m150.9 m159.3 m167.7 m177.5 m169.8 m193.9 m194 m

Current Assets

619.1 m637.5 m653.1 m691.2 m679.5 m727.5 m768.9 m882.6 m928.4 m1.3 b
    USDFY, 2014FY, 2015FY, 2016

    Net Income

    15.2 m210.3 m111.2 m

    Depreciation and Amortization

    142.9 m140.8 m140.6 m

    Cash From Operating Activities

    178.3 m171.8 m155.3 m

    Capital Expenditures

    122.4 m141 m139.6 m
    USDQ1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018

    Net Income

    39.5 m49.3 m4.6 m22 m26 m3.8 m

    Depreciation and Amortization

    35 m70.2 m104.6 m35.5 m70.7 m105.5 m35.8 m71.3 m107.8 m

    Accounts Receivable

    410.5 m


    194 m
      USDY, 2017


      50.4 k

      Financial Leverage

      3.6 x
      Show all financial metrics

      Catalent Operating Metrics

      Catalent's Customers was reported to be 1 k in FY, 2016. Catalent's Backlog was reported to be 827.5 m in FY, 2016
      FY, 2015FY, 2016


      827.6 m827.5 m

      Patents Issued

      1.1 k


      7 k


      1 k
      Show all operating metrics

      Catalent Market Value History

      Catalent Revenue Breakdown

      Catalent's Web-traffic and Trends

      Catalent Online and Social Media Presence

      Catalent News and Updates

      Contract Pharmaceutical Manufacturing Global Market 2017: Key Players – Catalent, DPx, Lonza, Piramal Healthcare, Aenova

      Contract Pharmaceutical Manufacturing -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2022 Posted via Industry Today. Follow us on Twitter @IndustryToday

      Clinical Trial Supplies Market 2017 Global Key Vendors Analysis, Revenue, Trends & Forecast to 2022

      Wiseguyreports.Com adds “Clinical Trial Supplies Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

      Sterilized Packaging Market: Top Competitive Players & Industry Growth Drivers, 2024

      Rising demand from biologics market for monoclonal, antibodies, protein cell, therapy cells, regenerative medicines, and others is anticipated to boost the global sterilized packaging market growth in future. Posted via Industry Today. Follow us on Twitter @IndustryToday

      Blow Fill Seal Technology Market to Yeild at 8.7% CAGR through 2027

      Future Market Insights has announced the addition of the “Blow Fill Seal Technology Market: Global Industry Analysis and Opportunity Assessment, 2017-2027"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday

      Catalent Company Life and Culture

      You may also be interested in